VIZIENT, INC. for VIZIENT INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Inflation Reduction Act (H.R. 5376) - Supported inclusion of 4,000 Medicare-supported Graduate Medical Education slots as part of the Inflation Reduction Act. Supported policies to encourage health care coverage and close the Medicaid coverage gap. Monitored impact of Medicare reimbursement provisions for prescription drugs in final legislation. Medicare Provider Reimbursement - Raised concerns about adequacy of payment updates through annual payment rules and urged Congress to provide additional support. Advocated for Congress to extend Medicare sequestration relief through the end of the COVID-19 Public Health Emergency and act to prevent sequestration cuts beginning in 2023 due to statutory PAYGO requirements. Medicare Physician Reimbursement - Supported passage of Supporting Medicare Providers Act (H.R. 8800) to ease pending reimbursement cuts through the physician fee schedule conversion factor. Health Care Workforce - Supported legislation (S.834/H.R. 2256; S. 1438) to increase the number of Medicare-supported Graduate Medical Education slots. Supported the Opioid Workforce Act (S. 1438 /H.R. 3441). Advanced Alternative Payment Model (APMs) Bonus Payment - Supported passage of the Value in Healthcare Act (H.R. 4587) to extend the APM bonus payments. Strengthen Kids Mental Health Now Act (H.R. 7236). Telehealth - Advocated for Congress to extend or make permanent flexibilities related to distant site and geographic limitations, expanding the provider types and services available to be reimbursed by Medicare. Urged passage of the CONNECT for Health Act (S. 1512/H.R. 2903). Supported passage of Advancing Telehealth Beyond COVID-19 Act (H.R. 4040). Social Determinants of Health and Health Equity - Engaged and offered feedback on proposals from CMS to provide resources and context to better assess patient obstacles to accessing health care and their impact on health care outcomes. Supported passage of the Hospital Inpatient Services Modernization Act (S. 3792/H.R. 7053). Supported passage of the Improving Seniors' Timely Access to Care Act (S.3018/ H.R.3173). Supported passage of the Preserving Access to Home Infusion Act (H.R. 5067/S. 2652).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXANDRIA LEIGH ICENHOWER New | — |
| SHOSHANA KRILOW | — |
| STEVEN RIXEN | — |
| JENNA STERN | — |
| DARREN WEBB | — |
Health Issues HCR
Healthcare Supply Chain - Highlighted the important role played by hospital group purchasing organizations in promoting resiliency and value in healthcare purchasing. Provided information on ongoing efforts to reduce greenhouse gas emissions and support environmentally preferred sourcing for healthcare supplies. Engaged to support policies to ensure greater transparency and mitigate or limit shortages of prescription drugs. Supported policies that would expedite critical cargo, including cargo necessary for medical care, during a public health emergency or disaster. Food and Drug Administration User Fee Amendments - Supported passage of legislation to extend user-fee authorities ((S. 4348, H.R.7667, H.R. 6833). Advocated for greater transparency in the health care supply chain for drugs and medical devices. Supported updating language related to the Unapproved Drugs Initiative, and incorporating the PASTUER Act (S.2076) and the PATCH Act (H.R. 7084) in final passage. Inflation Reduction Act (H.R. 5376) - Supported extension of enhanced subsidies through the health insurance marketplace. Supported provisions that would increase reimbursement for biosimilar medications and monitored impact of other policies impacting prices of prescription drugs. Public Health Emergency - Advocated for HHS to further extend the declared Public Health Emergency. Telehealth - Supported efforts to make telehealth flexibilities offered during COVID-19 Public Health Emergency permanent. Supported CONNECT for Health Act (S. 1512/H.R. 2903) and the Extending Telehealth Beyond COVID-19 Act (H.R. 4040). Encouraged reimbursement parity for certain telehealth services and support for audio-only telehealth services. Health Care Workforce - Urged passage of the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act (H.R. 708; S. 168); The Health Care Workforce Resilience Act (S. 1024/H.R. 2255); The Resident Physician Shortage Reduction Act (S.834/H.R. 2256). The Opioid Workforce Act (S. 1438/H.R. 3441). Urged administration to examine practices of health care staffing agencies. Supported passage of the Travel Nursing Agency Transparency Study Act (S. 4352). Supported passage of the Safety from Violence for Healthcare Employees Act (H.R. 7961). Prepare for and Respond to Existing Viruses, Emerging New Threats, and (PREVENT) Pandemics Act (S. 3799) - monitored PREVENT Pandemics Act and supported inclusion of provisions to improve supply chain transparency and extend shelf life of prescription drugs. Supported passage of the Integrity, Notification, Fairness in Online Retail Marketplaces (INFORM) Consumers Act (S. 963/H.R. 5502). 340B Drug Pricing Program - Urged HHS to enforce guidance that would allow 340B Covered Entities to utilize contract pharmacies. Social Determinants of Health and Health Equity - Shared insights and offered suggestions to CMS regarding health equity measurement, indices and data collection. Supported the Social Determinants Accelerator Act (H.R. 2503; S. 3039); The LINC to Address Social Needs Act (S. 509). Antimicrobial resistance (S. 2076) - Supported passage of the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act. Supported passage of Opioid Treatment Access Act (S. 3629/H.R. 6279). Supported passage of Drug Shortage Shelf Life Extension Act (S. 3493). Supported passage of the Hospital Inpatient Services Modernization Act (S. 3792/H.R. 7053).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXANDRIA LEIGH ICENHOWER New | — |
| SHOSHANA KRILOW | — |
| STEVEN RIXEN | — |
| JENNA STERN | — |
| DARREN WEBB | — |
Tariff (miscellaneous tariff bills) TAR
Urged administration to continue tariff exclusions for medical products needed to respond to the COVID-19 pandemic.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXANDRIA LEIGH ICENHOWER New | — |
| SHOSHANA KRILOW | — |
| STEVEN RIXEN | — |
| JENNA STERN | — |
| DARREN WEBB | — |
Taxation/Internal Revenue Code TAX
Provided information and education related to tax exemption and hospital community benefit requirements.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEXANDRIA LEIGH ICENHOWER New | — |
| SHOSHANA KRILOW | — |
| STEVEN RIXEN | — |
| JENNA STERN | — |
| DARREN WEBB | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.